Location History:
- Gent, BE (2007 - 2010)
- Ghent, BE (2012)
Company Filing History:
Years Active: 2007-2012
Title: Veerle De Maere: Innovator in Vaccine Development
Introduction
Veerle De Maere is a prominent inventor based in Gent, Belgium. She has made significant contributions to the field of vaccine development, particularly through her innovative research and patents. With a total of three patents to her name, her work focuses on nucleic acid sequences and their applications in immunology.
Latest Patents
One of her latest patents is the Ostertagia vaccine, which relates to nucleic acid sequences encoding a 30 kD lipoprotein. This invention includes parts of such nucleic acid sequences that encode immunogenic fragments of lipoproteins. It also encompasses DNA fragments, recombinant DNA molecules, live recombinant carriers, and host cells that comprise these nucleic acid sequences. The invention further extends to vaccines that utilize these components for diagnostic or vaccination purposes. Another aspect of her patent involves proteins and immunogenic parts encoded by nucleic acid sequences, emphasizing their use in vaccine manufacturing and diagnostic kits.
Career Highlights
Veerle De Maere is affiliated with Universiteit Gent, where she conducts her research and development work. Her innovative approach to vaccine technology has positioned her as a key figure in her field.
Collaborations
She collaborates with notable colleagues such as Edwin Claerebout and Peter Geldhof, contributing to a dynamic research environment that fosters innovation.
Conclusion
Veerle De Maere's work in vaccine development exemplifies the impact of innovative research on public health. Her contributions through patents and collaborations continue to advance the field of immunology.